Description
The Finecare™ Lp-PLA2 Rapid Quantitative Test is designed for the quantitative measurement of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in human whole blood, serum, or plasma samples.
Using fluorescence immunoassay technology with a compatible Finecare™ FIA System, this test provides quantitative results within approximately 15 minutes. It is used as an aid in assessing coronary heart disease (CHD) and ischemic stroke.
Key Features
- Quantitative Lp-PLA2 measurement
- Fluorescence immunoassay technology
- Results available in approximately 15 minutes
- Compatible with whole blood, serum, and plasma
- Supports coronary heart disease assessment
- Supports ischemic stroke risk assessment
Technical Specifications
| Parameter | Details |
|---|---|
| Cat. No. | W242 |
| Test Item | Lp-PLA2 |
| Specimen | Serum / Plasma / Whole Blood |
| Reaction Time | 15 minutes |
| Measuring Range | 10–1000 ng/mL |
| Qualification | CE, NMPA |
Intended Use
The Finecare™ Lp-PLA2 Rapid Quantitative Test is a fluorescence immunoassay intended for the quantitative determination of Lp-PLA2 in human serum, plasma, or whole blood using a compatible Finecare™ FIA System. It is used as an aid in the assessment of coronary heart disease and ischemic stroke.
Storage and Stability
- Store the test kit at 4–30°C until the expiration date printed on the package.
- If refrigerated, allow the kit to reach room temperature for 30 minutes before testing.
- Keep the test cartridge sealed until use.
- Use the test cartridge within one hour after opening the pouch.
